ANDA 75916, held by Impax Labs Inc. Rimantadine Hydrochloride.
As of Nov 16, 2026, ANDA 75916 (Rimantadine Hydrochloride), held by Impax Labs Inc, was first approved by FDA on Nov 2, 2001, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 2, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Rimantadine Hydrochloride100MG ยท tablet;oral | Rimantadine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters